Literature DB >> 1425893

Nonlinearity of amoxicillin absorption kinetics in human.

G Paintaud1, G Alván, M L Dahl, A Grahnén, J Sjövall, J O Svensson.   

Abstract

Specialised gastrointestinal absorption of amoxicillin has been suggested in man and has been demonstrated in animals. In order to study the rate and extent of amoxicillin absorption, six healthy subjects were given 500 mg IV and two oral doses (500 mg and 3 g as a suspension). Absorption kinetics was analysed by compartmental modelling, noncompartmental methods and by calculation of absorption rates using deconvolution. Dose-dependency of the extent of amoxicillin absorption was observed, with a lower than expected mean maximum plasma concentration (49%), and fraction of the dose absorbed (39%) after the 3 g dose calculated from the 500 mg dose, assuming kinetic linearity. Zero-order kinetics of absorption was apparent in some subjects after the 500 mg dose, both from model fitting and absorption rate profile. However, no pattern consistent with pure first-order or zero-order absorption was observed after both oral doses in any individual. The dose-dependency of amoxicillin absorption was confirmed by a trend to an increased time of absorption for the high dose. The results show the variable nature and nonlinearity of the gastrointestinal absorption of amoxicillin and indicate the involvement of a number of factors, in addition to simple diffusion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1425893     DOI: 10.1007/bf02333024

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  24 in total

1.  Effect of dose-concentration on the absorption of amoxicillin and ampicillin from the rat intestine.

Authors:  A Tsuji; E Nakashima; I Kagami; N Honjo; T Yamana
Journal:  J Pharm Pharmacol       Date:  1977-11       Impact factor: 3.765

2.  Saturable rate of cefatrizine absorption after oral administration to humans.

Authors:  B G Reigner; W Couet; J P Guedes; J B Fourtillan; T N Tozer
Journal:  J Pharmacokinet Biopharm       Date:  1990-02

3.  Physicochemical properties of amphoteric beta-lactam antibiotics I: Stability, solubility, and dissolution behavior of amino penicillins as a function of pH.

Authors:  A Tsuji; E Nakashima; S Hamano; T Yamana
Journal:  J Pharm Sci       Date:  1978-08       Impact factor: 3.534

4.  A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability.

Authors:  D J Schuirmann
Journal:  J Pharmacokinet Biopharm       Date:  1987-12

5.  Estimation of drug absorption rates using a deconvolution method with nonequal sampling times.

Authors:  K Iga; Y Ogawa; T Yashiki; T Shimamoto
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

6.  Bioavailability of ampicillin and amoxicillin in fasted and nonfasted subjects.

Authors:  P G Welling; H Huang; P A Koch; W A Craig; P O Madsen
Journal:  J Pharm Sci       Date:  1977-04       Impact factor: 3.534

7.  Intestinal absorption mechanism of amino-beta-lactam antibiotics. III. Kinetics of carrier-mediated transport across the rat small intestine in situ.

Authors:  E Nakashima; A Tsuji; S Kagatani; T Yamana
Journal:  J Pharmacobiodyn       Date:  1984-07

8.  Oral cyclacillin interacts with the absorption of oral ampicillin, amoxycillin, and bacampicillin.

Authors:  J Sjövall; G Alván; D Westerlund
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

9.  Predicting fraction dose absorbed in humans using a macroscopic mass balance approach.

Authors:  P J Sinko; G D Leesman; G L Amidon
Journal:  Pharm Res       Date:  1991-08       Impact factor: 4.200

10.  Intra- and inter-individual variation in pharmacokinetics of intravenously infused amoxycillin and ampicillin to elderly volunteers.

Authors:  J Sjövall; G Alván; B Huitfeldt
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

View more
  20 in total

Review 1.  Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug development.

Authors:  Jaime A Yáñez; Connie M Remsberg; Casey L Sayre; M Laird Forrest; Neal M Davies
Journal:  Ther Deliv       Date:  2011-05

Review 2.  New formulations of amoxicillin/clavulanic acid: a pharmacokinetic and pharmacodynamic review.

Authors:  Amparo Sánchez Navarro
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

3.  Analysis of the pharmacokinetic interaction between cephalexin and quinapril by a nonlinear mixed-effect model.

Authors:  C Padoin; M Tod; G Perret; O Petitjean
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

Review 4.  Pharmacokinetic considerations in the eradication of Helicobacter pylori.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

5.  Impact of Bariatric Surgery on the Pharmacokinetics Parameters of Amoxicillin.

Authors:  Marina Becker Sales Rocha; Gilberto De Nucci; Francisco Ney Lemos; Rodrigo Feitosa de Albuquerque Lima Babadopulos; Andrea Vieira Pontes Rohleder; Francisco Vagnaldo Fechine; Natalícia J Antunes; Gustavo D Mendes; Demetrius Fernandes do Nascimento; Manoel Odorico de Moraes; Maria Elisabete Amaral de Moraes
Journal:  Obes Surg       Date:  2019-03       Impact factor: 4.129

6.  Dose proportional absorption of 25-150 mg atenolol.

Authors:  M Wakelkamp; G Alván; G Paintaud; A Hedman
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Hollow-fiber pharmacodynamic studies and mathematical modeling to predict the efficacy of amoxicillin for anthrax postexposure prophylaxis in pregnant women and children.

Authors:  Arnold Louie; Brian Vanscoy; Weiguo Liu; Robert Kulawy; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

8.  Development and validation of limited-sampling strategies for predicting amoxicillin pharmacokinetic and pharmacodynamic parameters.

Authors:  G Suarez-Kurtz; F M Ribeiro; F L Vicente; C J Struchiner
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

9.  Evaluating barriers to bioavailability in vivo: validation of a technique for separately assessing gastrointestinal absorption and hepatic extraction.

Authors:  Laura Letendre; Mark Scott; Glenn Dobson; Ismael Hidalgo; Bruce Aungst
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

10.  Lack of effect of amoxycillin on the absorption of ofloxacin.

Authors:  G Paintaud; G Alván; U Hellgren; I Nilsson-Ehle
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.